Palomar (NASDAQ:PLMR) Insider Angela Grant Sells 1,447 Shares of Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) insider Angela Grant sold 1,447 shares of Palomar stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $119.88, for a total value of $173,466.36. Following the completion of the transaction, the insider owned 5,242 shares in the company, valued at $628,410.96. This trade represents a 21.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Palomar Stock Performance

PLMR stock opened at $123.59 on Friday. Palomar Holdings, Inc. has a one year low of $104.47 and a one year high of $175.85. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 19.28 and a beta of 0.42. The firm has a 50-day simple moving average of $127.65 and a two-hundred day simple moving average of $123.95.

Palomar (NASDAQ:PLMR) last posted its quarterly earnings data on Thursday, November 6th. The company reported $2.01 EPS for the quarter, topping the consensus estimate of $1.56 by $0.45. The firm had revenue of $244.66 million during the quarter, compared to analyst estimates of $207.98 million. Palomar had a net margin of 22.59% and a return on equity of 21.93%. During the same quarter in the previous year, the business posted $1.23 EPS. As a group, equities analysts predict that Palomar Holdings, Inc. will post 5.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently issued reports on PLMR. Keefe, Bruyette & Woods upped their target price on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research report on Tuesday, January 6th. JPMorgan Chase & Co. upped their price objective on shares of Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Wednesday, January 7th. Weiss Ratings upgraded shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Finally, Wall Street Zen raised shares of Palomar from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Six research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Palomar currently has an average rating of “Moderate Buy” and a consensus target price of $159.50.

More Palomar News

Here are the key news stories impacting Palomar this week:

• Neutral Sentiment: Yahoo Finance published a piece asking whether PLMR’s recent price slide creates a long‑term buying opportunity — a constructive framing for value investors but speculative. Is Palomar Holdings (PLMR) Price Slide Creating A Long Term Opportunity For Investors
• Negative Sentiment: CEO Mac Armstrong sold 11,484 shares at $119.88 (≈$1.38M); his post-sale holding is 91,737 shares (11.13% decrease). SEC filing: CEO Sale Filing
• Negative Sentiment: President Jon Christianson sold 1,991 shares at $119.88 (≈$238.7k); post-sale holding 62,985 shares (3.06% decrease). SEC filing: President Sale Filing
• Negative Sentiment: CFO T. Christopher Uchida sold 2,103 shares at $119.88 (≈$252.1k); post-sale holding 11,473 shares (15.49% decrease). SEC filing: CFO Sale Filing
• Negative Sentiment: Insider Jonathan Knutzen sold 1,535 shares at $119.88 (≈$184.0k); post-sale holding 24,809 shares (5.83% decrease). SEC filing: Insider Sale Filing
• Negative Sentiment: Insider Angela L. Grant sold 1,447 shares at $119.88 (≈$173.5k); post-sale holding 5,242 shares (21.63% decrease). SEC filing: Insider Sale Filing

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PLMR. Invesco Ltd. boosted its position in Palomar by 234.1% in the second quarter. Invesco Ltd. now owns 798,361 shares of the company’s stock valued at $123,147,000 after buying an additional 559,383 shares during the last quarter. Alliancebernstein L.P. raised its position in Palomar by 290.2% during the 2nd quarter. Alliancebernstein L.P. now owns 497,080 shares of the company’s stock worth $76,675,000 after buying an additional 369,697 shares during the last quarter. Westfield Capital Management Co. LP lifted its stake in Palomar by 81.0% during the 3rd quarter. Westfield Capital Management Co. LP now owns 738,528 shares of the company’s stock valued at $86,223,000 after acquiring an additional 330,592 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Palomar by 72.1% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 785,165 shares of the company’s stock valued at $105,809,000 after acquiring an additional 328,993 shares during the last quarter. Finally, AustralianSuper Pty Ltd purchased a new stake in shares of Palomar in the 2nd quarter valued at $37,253,000. 90.25% of the stock is currently owned by hedge funds and other institutional investors.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.